Synopsis of recent research by authors named "Anbok Lee"
- Anbok Lee's recent research focuses on integrating advanced biological techniques such as metabolomics, machine learning, and microbiome analysis to enhance breast cancer diagnosis, prognosis, and treatment, particularly targeting early-stage and estrogen receptor-positive breast cancer.
- Key findings include novel metabolomic biomarkers for early breast cancer detection, insights into microbiome changes due to neoadjuvant chemotherapy, and the influence of mammographic breast density reduction on treatment outcomes, suggesting significant implications for patient management.
- Additionally, studies on the safety and effectiveness of pegfilgrastim for preventing chemotherapy-induced febrile neutropenia and the exploration of combination therapies in HER2-positive breast cancer highlight innovative approaches to improve therapeutic efficacy and patient safety.
